Improved Survival after Transarterial Radioembolisation for Hepatocellular Carcinoma Gives the Procedure Added Value.
Cristina MosconiAlberta CappelliCinzia PettinatoMaria Adriana CocozzaGiulio VaraEleonora TerziMaria Cristina MorelliElisa Lodi RizziniMatteo RenzulliFrancesco ModestinoMatteo SerenariRachele BonfiglioliLetizia CalderoniElena TabacchiMatteo CesconAlessio Giuseppe MorgantiFranco TrevisaniPiscaglia FabioStefano FantiLidia StrigariAlessandro CucchettiRita GolfieriPublished in: Journal of clinical medicine (2022)
Better patient selection, refinement of technique and adoption of personalised dosimetry improved survival after TARE. Conversely, sorafenib after TARE did not impact life expectancy.